Long acting beta-2 agonists in the treatment of asthma and their safety; [Astım tedavisinde uzun etkili beta-2 agonistlerin yeri ve güvenilirliǧi]

Simple item page
dc.contributor.authorTürktaş H.
dc.contributor.authorŞekerel B.
dc.contributor.authorKarakaya G.
dc.contributor.authorYildiz F.
dc.contributor.authorYorgancioǧlu A.
dc.date.accessioned2024-07-22T08:20:20Z
dc.date.available2024-07-22T08:20:20Z
dc.date.issued2011
dc.description.abstractInhaled corticosteroids are the preferred primary long-term treatment for asthma. The first option in patients who are uncontrolled with inhaled steroids is adding long-acting beta-2 agonists. The addition of a long-acting beta-agonist to an inhaled corticosteroid has been accepted as effective therapy for almost two decades Despite the widespread use and their clinical benefit, controversy regarding their safety arose after their introduction. Concerns about the safety of long-acting beta-2 agonist therapy, has led to the appearance of multiple publications and recommendations. The evidence supports the use of long-acting beta-2 agonists plus inhaled corticosteroids in a single inhaler device to increase adherence and reduce the potential use of long-acting beta-2 agonists monotherapy. This review examines and commands on the available clinical data and safety concerns of long-acting beta-2 agonists use in patients with asthma.
dc.identifier.DOI-ID10.5578/tt.3269
dc.identifier.issn04941373
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/18091
dc.language.isoEnglish
dc.publisherAnkara University
dc.rightsAll Open Access; Green Open Access; Hybrid Gold Open Access
dc.subjectAdministration, Inhalation
dc.subjectAdrenal Cortex Hormones
dc.subjectAdrenergic beta-Agonists
dc.subjectAnti-Asthmatic Agents
dc.subjectAsthma
dc.subjectHumans
dc.subjectbeta 2 adrenergic receptor stimulating agent
dc.subjectcorticosteroid
dc.subjectantiasthmatic agent
dc.subjectbeta adrenergic receptor stimulating agent
dc.subjectcorticosteroid
dc.subjectadd on therapy
dc.subjectasthma
dc.subjectclinical study
dc.subjectdrug safety
dc.subjectevidence based practice
dc.subjectinhaler
dc.subjectpatient compliance
dc.subjectpublication
dc.subjectreview
dc.subjectasthma
dc.subjecthuman
dc.subjectinhalational drug administration
dc.titleLong acting beta-2 agonists in the treatment of asthma and their safety; [Astım tedavisinde uzun etkili beta-2 agonistlerin yeri ve güvenilirliǧi]
dc.typeReview

Files

Collections

Scopus Koleksiyonu